Value proposition

We use AI to predict chronic kidney disease (CKD), far earlier than existing methods.

Fourth Vital is at the forefront of CKD prevention, developing AI-powered early-warning systems focused on "Volume Status Vector" assessment. Based on clinically proven methods, this groundbreaking technology integrates physiological and social biomarkers to uncover early-stage patterns missed by traditional diagnostics.

CKD is irreversible. Yet most cases can be avoided with early intervention. 90% of people with the condition remain unaware until it’s too late. Current diagnostic methods, such as blood and urine tests, identify CKD only in its advanced stages – when treatment can slow progression, but not prevent the inevitable suffering. By 2034, CKD is projected to affect over 15% of the global population, with treatment costs exceeding USD $1.6 trillion annually.

Fourth Vital has also crafted advanced analytics, intuitive visualizations, and user-friendly tools to help physicians treating patients with CKD.

Our mission is to improve the quality of life for millions while reducing healthcare costs by over USD $150 billion annually in the United States alone.
Fourth Vital systems help reduce hospitalizations, aid physicians in optimizing CKD treatment, and significantly reduce the annual cost of CKD management, which are currently $100BN in the USA and over CAD$40BN in Canada.

Chronic Kidney Disease, AI/ML, SaaS, and Software